ANDA 77211, held by Ranbaxy Labs Ltd. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 77211 (Metformin Hydrochloride), held by Ranbaxy Labs Ltd, was first approved by FDA on Jun 29, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride750MG ยท tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters